Chest X-ray and Chest CT in Shanghai Check-up Packages

The twelve-package chest-item matrix

All prices below are USD per person for the whole listed package. They are not standalone imaging fees or direct-booking hospital tariffs. A higher price does not prove that an imaging examination is more appropriate, and identical chest wording does not mean the rest of the packages match.

Scroll horizontally to see all columns.

Sources R are Renji HTML plus linked PDFs; sources H are Huadong HTML. All were checked on 13 October 2026. The exact source URLs and version dates appear below. This is a two-hospital catalogue sample, not an inventory of every Shanghai provider.

Three observations worth taking into an enquiry

1. Renji option 01 names X-ray for both catalogue labels. Its 02 and 03 lists instead name low-dose lung CT. The catalogue does not promise both examinations in the same package. If a clinician has requested one specific study, preserve that wording rather than accepting “chest imaging” as an equivalent answer.
2. Huadong names chest CT in all six lists. The row does not state a low-dose protocol. Do not add “low dose” when summarising it, and do not assume that its protocol matches Renji’s. This is a missing specification, not evidence of a particular higher-dose protocol.
3. Physical film is a separate scope question. All six Renji chest rows and Huadong HM2/HM3 expressly exclude physical film. The other Huadong rows leave that point unclear. Neither statement establishes whether downloadable image files are provided or how long they remain accessible.

For Renji’s men-labelled options, the published whole-package increase from 01 to 02 is US$252; for its women-labelled options it is US$235. Many other rows also change. Neither difference can honestly be described as “the cost to upgrade X-ray to CT.” A separately requested change needs its own accepted quotation.

Huadong’s listed chest wording stays the same as its package prices change. That provides another reason not to use a higher package total as a proxy for a more extensive chest study. Ask for the actual protocol and clinically accepted scope.

Why the labels are medically different

A conventional radiograph records an X-ray image; CT uses specialised X-ray equipment to reconstruct cross-sectional images. Both involve ionising radiation. FDA guidance says radiography generally uses less radiation than CT, but the dose depends on the particular procedure. These catalogue pages do not provide patient-specific dose estimates. FDA radiography, FDA CT

The FDA advises discussing CT benefits, risks and previous imaging with the clinician, who should justify the examination and consider alternatives when appropriate. A “low-dose” label does not establish that CT is indicated for every person. This article supplies no screening eligibility rule, frequency or recommendation to replace one examination with another. FDA CT

A scope-check decision tool

Use the following path to turn an ambiguous chest-imaging request into a reviewable plan. It deliberately ends in confirmed information or a question, rather than an automatic purchase recommendation.

Scroll horizontally to see all columns.

Worked example: comparing Renji Men’s 01 at US$480 with Huadong Men’s 01 at US$320 does not compare two differently priced versions of the same scan. The first explicitly names chest X-ray and the second chest CT. The sensible outcome is a scope clarification and clinical discussion, not “CT is cheaper so choose CT.” The totals also cover different wider examination lists and require current appointment confirmation.

Questions to settle before payment

Ask the hospital or coordinator to record:

• The exact accepted examination name, region and protocol, including whether any contrast is required and separately priced.
• Who confirms appropriateness and reviews relevant previous imaging.
• Any safety or eligibility information the hospital needs through its private clinical process, including possible pregnancy where relevant; do not self-clear an examination from a package card.
• Whether the chest study is at the confirmed campus on the check-up day or needs another appointment.
• Whether the output includes the original report, English translation, accessible image files and physical film; record each separately.
• What happens to the price and schedule if a clinician advises against the listed test or proposes a different one.

Do not assume an excluded physical film means no diagnostic images are produced, or that an English report automatically includes portable image files. These are different deliverables and need different answers.

For a requested scan outside the package, use the Shanghai MRI, CT and ultrasound additions guide. It addresses the separate approval, price and appointment questions. For current city choices and a written plan, use Shanghai prices, English support and booking. An enquiry does not reserve a slot, and a commercial list is not medical clearance.

Dated sources and evidence limits

Renji HTML pages state a 4 October 2026 package update and a 7 October presentation check. Their linked PDFs have 20261004 in the filenames but visible 10 October 2026 footers. The chest wording, physical-film exclusion and price agree across the reviewed HTML and PDF versions. Preserve both dates when asking which document governs a quotation.

• RM1: men-1 HTML; RM1 PDF
• RM2: men-2 HTML; RM2 PDF
• RM3: men-3 HTML; RM3 PDF
• RW1: women-1 HTML; RW1 PDF
• RW2: women-2 HTML; RW2 PDF
• RW3: women-3 HTML; RW3 PDF

Huadong HTML pages display a 7 October 2026 presentation check and structured metadata dated 10 October. They explicitly distinguish a presentation check from a new hospital tariff confirmation. No package PDFs were linked from the checked six pages or the hospital directory. Their evidence is therefore HTML-only, with no inferred protocol or exclusion.

• HM1: men-1 HTML
• HM2: men-2 HTML
• HM3: men-3 HTML
• HW1: women-1 HTML
• HW2: women-2 HTML
• HW3: women-3 HTML

The chest matrix maps each price to the corresponding page’s displayed whole-package total and each imaging statement to its chest row. Film status follows the row’s explicit note; silence is labelled unclear. FDA’s CT “Description,” “Benefits/Risks” and patient/provider guidance, and its radiography “Description” and “Risks/Benefits” sections were checked on 13 October 2026 solely for the short modality explanation above. They do not validate any commercial package.

Still unverified: current hospital acceptance, individual eligibility, exact protocol and dose, contrast use, digital-image terms, substitutions and standalone imaging prices. New source material should be reconciled against this dated comparison; neither an older filename nor a newer webpage timestamp alone resolves a clinical or commercial difference.